English
|
Español
English
|
Español
Insurance
Marketing
Pharmaceuticals
Technology/Innovation
Regulatory
Community
Krystal Biotech
Pacient Daily
| May 22, 2023
Krystal Biotech Receives FDA Approval for the First-Ever Redosable Gene Therapy, VYJUVEK™ (beremagene geperpavec-svdt) for the Treatment of Dystrophic Epidermolysis Bullosa
Patient Daily
| Apr 26, 2023
Krystal Biotech to Present at Association for Research in Vision and Ophthalmology Annual Meeting
Patient Daily
| Apr 24, 2023
Krystal Biotech to Present at Association for Research in Vision and Ophthalmology Annual Meeting
Patient Daily
| Apr 24, 2023
Jeune Aesthetics Announces Dosing of First Subject in Phase 1, Cohort 3 Study of KB301 for the Improvement of Lateral Canthal Lines at Rest
Trending
Patient Daily
| Jul 15, 2025
Scottsdale Sinus & Allergy Center garners 500+ Google reviews with a 4.9-star rating
Patient Daily
| Jul 11, 2025
Physician assistant on headaches and sinusitis: ‘Sinus headaches are known to trigger your migraines’
Patient Daily
| Jul 15, 2025
Gulf Coast Breathe Free Sinus & Allergy Centers earns 250+ Google reviews with a 4.9-star rating
+
Pharmaceuticals
Patient Daily
| Jul 10, 2025
PhRMA Executive VP: ‘State policymakers can lead the way and must address 340B abuse and protect patients from PBMs'
